Clinical Trial Update: PegvisOMant and the Immune SystEm (PROMISE)

View source ↗

Summary

The PROMISE trial, sponsored by the University of Roma La Sapienza, studied pegvisomant in acromegaly with an emphasis on immune-system effects. The trial statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• Somavert (pegvisomant)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Acromegaly | Status: COMPLETED